METRONIDAZOLE PHARMACOKINETICS IN PATIENTS WITH HEPATIC-ENCEPHALOPATHY

被引：37

作者：

LOFT, S ^{[1
]}

SONNE, J ^{[1
]}

DOSSING, M ^{[1
]}

ANDREASEN, PB ^{[1
]}

机构：

[1] GENTOFTE UNIV HOSP,DEPT MED F,HELLERUP,DENMARK

来源：

SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY | 1987年 / 22卷 / 01期

关键词：

D O I：

10.3109/00365528708991867

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

页码：117 / 123

页数：7

共 22 条

[1]

ANDREASEN PB, 1975, SCAND J GASTROENTERO, V10, P293

[2] METRONIDAZOLE IN ANAEROBIC INFECTIONS - REVIEW OF ITS ACTIVITY, PHARMACOKINETICS AND THERAPEUTIC USE [J].

BROGDEN, RN ;

HEEL, RC ;

SPEIGHT, TM ;

AVERY, GS .

DRUGS, 1978, 16 (05) :387-417

[3]

CONN HO, 1977, GASTROENTEROLOGY, V72, P573

[4] DISPOSITION OF ORAL METRONIDAZOLE IN HEPATIC CIRRHOSIS AND IN HEPATOSPLENIC SCHISTOSOMIASIS [J].

DANESHMEND, TK ;

HOMEIDA, M ;

KAYE, CM ;

ELAMIN, AA ;

ROBERTS, CJC .

GUT, 1982, 23 (10) :807-813

[5] IMPAIRED ELIMINATION OF METRONIDAZOLE IN DECOMPENSATED CHRONIC LIVER-DISEASE [J].

DANESHMEND, TK ;

ROBERTS, CJC .

BRITISH MEDICAL JOURNAL, 1984, 288 (6414) :405-405

[6] A SIMPLE METHOD FOR DETERMINATION OF ANTIPYRINE CLEARANCE [J].

DOSSING, M ;

POULSEN, HE ;

ANDREASEN, PB ;

TYGSTRUP, N .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1982, 32 (03) :392-396

[7] IMPAIRED ELIMINATION OF METRONIDAZOLE IN DECOMPENSATED CHRONIC LIVER-DISEASE [J].

FARRELL, G ;

ZALUZNY, L ;

BAIRDLAMBERT, J ;

CVEJIC, M ;

BUCHANAN, N .

BRITISH MEDICAL JOURNAL, 1983, 287 (6408) :1845-1845

[8]

FARRELL G, 1983, HEPATOLOY, V4, P722

[9]

GIBALDI M, 1975, DRUGS PHARM SCI, V1, P148

[10]

GUGLER R, 1983, NEW ENGL J MED, V309, P1518

← 1 2 3 →